TY  - GEN
AU  - Vavricka,Stephan R
AU  - Bentele,Nicoletta
AU  - Scharl,Michael
AU  - Rogler,Gerhard
AU  - Zeitz,Jonas
AU  - Frei,Pascal
AU  - Straumann,Alex
AU  - Binek,Janek
AU  - Schoepfer,Alain M
AU  - Fried,Michael
TI  - Systematic assessment of factors influencing preferences of Crohn's disease patients in selecting an anti-tumor necrosis factor agent (CHOOSE TNF TRIAL)
SN  - 1536-4844
PY  - 2012///1220
KW  - Adalimumab
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Anti-Inflammatory Agents
KW  - administration & dosage
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Certolizumab Pegol
KW  - Crohn Disease
KW  - drug therapy
KW  - Female
KW  - Humans
KW  - Immunoglobulin Fab Fragments
KW  - Immunosuppressive Agents
KW  - therapeutic use
KW  - Infliximab
KW  - Infusions, Intravenous
KW  - Injections, Subcutaneous
KW  - Male
KW  - Middle Aged
KW  - Patient Preference
KW  - Polyethylene Glycols
KW  - Prognosis
KW  - Prospective Studies
KW  - Surveys and Questionnaires
KW  - Tumor Necrosis Factor-alpha
KW  - antagonists & inhibitors
KW  - Young Adult
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/ibd.21888
ER  -